In this paper, we add to the list of nutraceuticals and botanicals introduced earlier in our first article, The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents. Periodically, we will update the original list to highlight other agents that may be considered as additional treatments against SARS-CoV. Along with the original list, these agents can be considered as immunoadjuvants, protease inhibitors, ACE2 modulators, zinc ionophores, and anati-inflammatory agents. Additionally, some nutraceuticals and botanicals could potentially inhibit SARS-CoV-2 replication. Our recommendation is to use higher dosing and/or multiple agents when patient contextual factors (e.g., patient desire, pre-existing inflammation, multiple co-morbidities, higher risk, etc.) and/or therapeutic decision-making warrant such use.
To read more, please click here.
This article was viewed on the Institute for Functional Medicine website.
COVID-19 articles sourced from various authors.
